ATE450253T1 - Pharmazeutische flüssige suspensionen - Google Patents
Pharmazeutische flüssige suspensionenInfo
- Publication number
- ATE450253T1 ATE450253T1 AT04013422T AT04013422T ATE450253T1 AT E450253 T1 ATE450253 T1 AT E450253T1 AT 04013422 T AT04013422 T AT 04013422T AT 04013422 T AT04013422 T AT 04013422T AT E450253 T1 ATE450253 T1 AT E450253T1
- Authority
- AT
- Austria
- Prior art keywords
- liquid suspensions
- pharmaceutical liquid
- particles
- liquid
- pharmaceutical
- Prior art date
Links
- 239000006194 liquid suspension Substances 0.000 title 1
- 239000007788 liquid Substances 0.000 abstract 3
- 239000002245 particle Substances 0.000 abstract 3
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000005057 refrigeration Methods 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Ceramic Engineering (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00973483A EP1328255A1 (de) | 2000-10-13 | 2000-10-13 | Zusammenstzung und verfahren für injizierbare flüssigkeiten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE450253T1 true ATE450253T1 (de) | 2009-12-15 |
Family
ID=41401562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04013422T ATE450253T1 (de) | 2000-10-13 | 2000-10-13 | Pharmazeutische flüssige suspensionen |
Country Status (4)
| Country | Link |
|---|---|
| EP (2) | EP1452171B1 (de) |
| AT (1) | ATE450253T1 (de) |
| DE (1) | DE60043459D1 (de) |
| DK (1) | DK1452171T3 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2498774A (en) | 2012-01-27 | 2013-07-31 | Bruce Roser | Glass-stabilised biological materials and syringe |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR78151B (de) * | 1982-04-05 | 1984-09-26 | Alcon Lab Inc | |
| WO1987000196A1 (en) * | 1985-07-09 | 1987-01-15 | Quadrant Bioresources Limited | Protection of proteins and the like |
| GB9010742D0 (en) * | 1990-05-14 | 1990-07-04 | Quadrant Bioresources Ltd | Stabilization of biological macromolecular substances |
| US5496535A (en) * | 1991-04-12 | 1996-03-05 | Alliance Pharmaceutical Corp. | Fluorocarbon contrast media for use with MRI and radiographic imaging |
| WO1993018748A1 (en) * | 1992-03-19 | 1993-09-30 | Allergan, Inc. | Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid |
| DK0686045T3 (da) * | 1993-02-23 | 2001-03-05 | Genentech Inc | Stabilisering af med organisk opløsningsmiddel behandlede polypeptider med et hjælpestof |
| SK283026B6 (sk) * | 1994-08-04 | 2003-02-04 | Quadrant Holdings Cambridge Limited | Tuhý časticový prostriedok na terapeutické použitie a spôsob jeho prípravy |
| GB9705588D0 (en) * | 1997-03-18 | 1997-05-07 | Anglia Research Foundation | Stable particle in liquid formulations |
| EP1071465A1 (de) * | 1998-03-18 | 2001-01-31 | Ronai, Peter | Amorphe gläser zur stabilisierung von empfindlichen produkten |
| US6190701B1 (en) * | 1999-03-17 | 2001-02-20 | Peter M. Ronai | Composition and method for stable injectable liquids |
-
2000
- 2000-10-13 DK DK04013422.3T patent/DK1452171T3/da active
- 2000-10-13 EP EP04013422A patent/EP1452171B1/de not_active Expired - Lifetime
- 2000-10-13 AT AT04013422T patent/ATE450253T1/de not_active IP Right Cessation
- 2000-10-13 EP EP04010391A patent/EP1449523A1/de not_active Withdrawn
- 2000-10-13 DE DE60043459T patent/DE60043459D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK1452171T3 (da) | 2010-04-06 |
| DE60043459D1 (de) | 2010-01-14 |
| EP1452171B1 (de) | 2009-12-02 |
| EP1452171A3 (de) | 2004-11-10 |
| EP1449523A1 (de) | 2004-08-25 |
| EP1452171A2 (de) | 2004-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60219006D1 (de) | Modifizierte und stabilizierte gdf propeptide und ihre verwendungen | |
| DE60309731D1 (de) | Injizierbare pharmazeutische suspension in einer phiole mit zwei kammern | |
| DE60234945D1 (de) | Pulver zur nasalen verabreichung von wirkstoffen | |
| ATE395042T1 (de) | Darreichungsformen welche mikropartikel und treibgas enthalten | |
| ID26033A (id) | Metode penstabilan komposisi bahan farmasi dengan penggunaan khusus dari antioksidan | |
| BR0206551B1 (pt) | bolsa plástica de múltiplas pregas descartável e sistema para melhorar a descarga de um material bombeável de uma bolsa plástica. | |
| DE602004032573D1 (de) | Stabilisierte zusammensetzungen von faktor-vii-polypeptiden | |
| EA200400148A1 (ru) | Стабилизированная суспензионная лекарственная форма для перорального применения | |
| LU92749I2 (fr) | Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2) | |
| AR025243A1 (es) | Composicion liquida de pesticida. | |
| ITMI20021476A0 (it) | Macchina vibrante particolarmente studiata per l'estrazione la miscelazione e la separazione di materie organiche ed inorganiche sia liquide | |
| ATE411802T1 (de) | Kombinationspräparate von 1,4- benzothiepin-1,1- dioxidderivaten mit weiteren wirkstoffen und deren verwendung | |
| TWI255737B (en) | A straw for the conservation of small quantities of substances, in particular biological liquids | |
| BR0008661A (pt) | Absorventes para uso no manuseio de fluidoscomplexos | |
| DE60043459D1 (de) | Pharmazeutische flüssige Suspensionen | |
| EE200200614A (et) | Konteiner õõnsuses oleva aromaatse essentsiga | |
| DE602005025082D1 (de) | Nicht-lamellare zubereitungen von dioleoyl-phosphatidyl ethanolamin und polysorbat80 | |
| DE60045894D1 (de) | Extraktion von polysaccharide aus algenprotein und verwendung davon | |
| DE60218744D1 (de) | Partikuläre zusammensetzung enthaltend eine lipophile flüssigkeit | |
| EP1749538A4 (de) | Verfahren zur auslösung der differenzierung von regulatorischen t-zellen und ihrer proliferation mit gpi-anker-protein-agonisten und medizinische zusammensetzung dafür | |
| IL173929A (en) | Kahlalid F analogs and their pharmacy preparations | |
| BG104133A (bg) | Метод за получаване на невирапин хемихидрат и фармацевтичен състав, който го съдържа | |
| ATE424453T1 (de) | Mannosyl(1-2)glycosyl(1-2)glycerat zur stabilisierung und konservierung von biomaterialien | |
| SE0202725D0 (sv) | Anordning för magnetiskt inducerbar membrantransport | |
| RU2002129753A (ru) | Керамическая масса для изготовления стеновых кирпичных изделий |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |